Here are four things to know.
1. Admelog was approved to control blood sugar levels after eating in adults and children older than three with Type 1 diabetes as well as adults with Type 2 diabetes.
2. Sanofi’s drug is a biosimilar version of Eli Lilly’s drug Humalog, which earned Eli Lilly $696.2 million in the latest quarter, according to Reuters.
3. The drug is a short-acting insulin. Type 1 diabetics need both a long-acting insulin and short acting insulin.
4. Admelog was approved through the FDA’s abbreviated approval pathway.
More articles on supply chain:
Study: 95.7% of US pharma sales go through primary distributors
10 recent pharma layoffs
Teva considers 10k job cuts to meet cost reduction goal of up to $2B
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
